High-throughput formulation screening of therapeutic proteins

Martinus A H Capelle1, Tudor Arvinte2

  • 1Therapeomic Inc., c/o University of Geneva, Quai E-Ansermet 30, 1211 Geneva 4, Switzerland.

Summary

High-throughput screening (HTS) accelerates drug discovery by automating compound identification. This review highlights HTS for rapid protein formulation development, optimizing stable liquids and lyophilisates.

Related Concept Videos